Drug intelligence / Profile preview

acetaminophen + diphenhydramine hydrochloride

Development stage
Unknown
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Oral
01

Overview

Pain Relief PM is an over-the-counter (OTC) fixed-dose combination medication containing the non-opioid analgesic acetaminophen (paracetamol) and the first-generation antihistamine diphenhydramine hydrochloride. Acetaminophen acts primarily in the central nervous system to inhibit prostaglandin synthesis via cyclooxygenase (COX-1 and COX-2) inhibition, thereby relieving minor aches and pains. Diphenhydramine hydrochloride acts as an inverse agonist at central histamine H1 receptors, crossing the blood-brain barrier to induce drowsiness and promote sleep. This combination is indicated for the temporary relief of occasional headaches and minor aches and pains accompanied by sleeplessness.

Brand names
GoodSense Extra Strength Pain Relief PMH-E-B Extra Strength Pain Relief PMHealth Star Night Time Pain ReliefKroger Extra Strength Pain Reliever PMMapap PMNotts Pain Relief PMPain Relief PMPercogesic Extra StrengthRight Remedies Extra Strength PM Pain ReliefTylenol PMUnisom PM PainValuMeds Pain Relief PM
Other names
acetaminophen + diphenhydramineacetaminophen + diphenhydramine HClacetaminophen + diphenhydramine hydrochlorideacetaminophen and diphenhydramineacetaminophen and diphenhydramine HClacetaminophen and diphenhydramine hydrochlorideacetaminophen/diphenhydramineacetaminophen/diphenhydramine HClacetaminophen/diphenhydramine hydrochloride
02

Targets

HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on acetaminophen + diphenhydramine hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + diphenhydramine hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call